COVID-19 Impact on Steroids Market, Global Research Reports 2020-2021
This report covers market size and forecasts of Steroids, including the following market information:
Major competitors identified in this market include Sumitomo, Pfizer, Novartis, Merck, Sanofi, Bayer, GSK, AstraZeneca, Cipla, Zizhu Pharma, etc.
Based on the Region:
- Global Steroids Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
- Global Steroids Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
- Global Steroids Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
- Global Steroids Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K MT)
Major competitors identified in this market include Sumitomo, Pfizer, Novartis, Merck, Sanofi, Bayer, GSK, AstraZeneca, Cipla, Zizhu Pharma, etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- Corticosteroids
- Sex Hormones
- Topical
- Inhalation
- Injection
- Oral
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Steroids Industry
1.7 COVID-19 Impact: Steroids Market Trends
2 GLOBAL STEROIDS QUARTERLY MARKET SIZE ANALYSIS
2.1 Steroids Business Impact Assessment - COVID-19
2.1.1 Global Steroids Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Steroids Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Steroids Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 Global Steroids Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Steroids Factory Price by Manufacturers
3.3 Location of Key Manufacturers Steroids Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Steroids Market
3.5 Key Manufacturers Steroids Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON STEROIDS SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Corticosteroids
1.4.2 Sex Hormones
4.2 By Type, Global Steroids Market Size, 2019-2021
4.2.1 By Type, Global Steroids Market Size by Type, 2020-2021
4.2.2 By Type, Global Steroids Price, 2020-2021
5 IMPACT OF COVID-19 ON STEROIDS SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Topical
5.5.2 Inhalation
5.5.3 Injection
5.5.4 Oral
5.2 By Application, Global Steroids Market Size, 2019-2021
5.2.1 By Application, Global Steroids Market Size by Application, 2019-2021
5.2.2 By Application, Global Steroids Price, 2020-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Sumitomo
7.1.1 Sumitomo Business Overview
7.1.2 Sumitomo Steroids Quarterly Production and Revenue, 2020
7.1.3 Sumitomo Steroids Product Introduction
7.1.4 Sumitomo Response to COVID-19 and Related Developments
7.2 Pfizer
7.2.1 Pfizer Business Overview
7.2.2 Pfizer Steroids Quarterly Production and Revenue, 2020
7.2.3 Pfizer Steroids Product Introduction
7.2.4 Pfizer Response to COVID-19 and Related Developments
7.3 Novartis
7.3.1 Novartis Business Overview
7.3.2 Novartis Steroids Quarterly Production and Revenue, 2020
7.3.3 Novartis Steroids Product Introduction
7.3.4 Novartis Response to COVID-19 and Related Developments
7.4 Merck
7.4.1 Merck Business Overview
7.4.2 Merck Steroids Quarterly Production and Revenue, 2020
7.4.3 Merck Steroids Product Introduction
7.4.4 Merck Response to COVID-19 and Related Developments
7.5 Sanofi
7.5.1 Sanofi Business Overview
7.5.2 Sanofi Steroids Quarterly Production and Revenue, 2020
7.5.3 Sanofi Steroids Product Introduction
7.5.4 Sanofi Response to COVID-19 and Related Developments
7.6 Bayer
7.6.1 Bayer Business Overview
7.6.2 Bayer Steroids Quarterly Production and Revenue, 2020
7.6.3 Bayer Steroids Product Introduction
7.6.4 Bayer Response to COVID-19 and Related Developments
7.7 GSK
7.7.1 GSK Business Overview
7.7.2 GSK Steroids Quarterly Production and Revenue, 2020
7.7.3 GSK Steroids Product Introduction
7.7.4 GSK Response to COVID-19 and Related Developments
7.8 AstraZeneca
7.8.1 AstraZeneca Business Overview
7.8.2 AstraZeneca Steroids Quarterly Production and Revenue, 2020
7.8.3 AstraZeneca Steroids Product Introduction
7.8.4 AstraZeneca Response to COVID-19 and Related Developments
7.9 Cipla
7.9.1 Cipla Business Overview
7.9.2 Cipla Steroids Quarterly Production and Revenue, 2020
7.9.3 Cipla Steroids Product Introduction
7.9.4 Cipla Response to COVID-19 and Related Developments
7.10 Zizhu Pharma
7.10.1 Zizhu Pharma Business Overview
7.10.2 Zizhu Pharma Steroids Quarterly Production and Revenue, 2020
7.10.3 Zizhu Pharma Steroids Product Introduction
7.10.4 Zizhu Pharma Response to COVID-19 and Related Developments
8 SUPPLY CHAIN AND SALES CHANNELS ANALYSIS
8.1 Steroids Supply Chain Analysis
8.1.1 Steroids Supply Chain Analysis
8.1.2 Covid-19 Impact on Steroids Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Steroids Distribution Channels
8.2.2 Covid-19 Impact on Steroids Distribution Channels
8.2.3 Steroids Distributors
8.3 Steroids Customers
9 KEY FINDINGS
10 APPENDIX
10.1 About Us
10.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Steroids Industry
1.7 COVID-19 Impact: Steroids Market Trends
2 GLOBAL STEROIDS QUARTERLY MARKET SIZE ANALYSIS
2.1 Steroids Business Impact Assessment - COVID-19
2.1.1 Global Steroids Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Steroids Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Steroids Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 Global Steroids Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Steroids Factory Price by Manufacturers
3.3 Location of Key Manufacturers Steroids Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Steroids Market
3.5 Key Manufacturers Steroids Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON STEROIDS SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Corticosteroids
1.4.2 Sex Hormones
4.2 By Type, Global Steroids Market Size, 2019-2021
4.2.1 By Type, Global Steroids Market Size by Type, 2020-2021
4.2.2 By Type, Global Steroids Price, 2020-2021
5 IMPACT OF COVID-19 ON STEROIDS SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Topical
5.5.2 Inhalation
5.5.3 Injection
5.5.4 Oral
5.2 By Application, Global Steroids Market Size, 2019-2021
5.2.1 By Application, Global Steroids Market Size by Application, 2019-2021
5.2.2 By Application, Global Steroids Price, 2020-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Sumitomo
7.1.1 Sumitomo Business Overview
7.1.2 Sumitomo Steroids Quarterly Production and Revenue, 2020
7.1.3 Sumitomo Steroids Product Introduction
7.1.4 Sumitomo Response to COVID-19 and Related Developments
7.2 Pfizer
7.2.1 Pfizer Business Overview
7.2.2 Pfizer Steroids Quarterly Production and Revenue, 2020
7.2.3 Pfizer Steroids Product Introduction
7.2.4 Pfizer Response to COVID-19 and Related Developments
7.3 Novartis
7.3.1 Novartis Business Overview
7.3.2 Novartis Steroids Quarterly Production and Revenue, 2020
7.3.3 Novartis Steroids Product Introduction
7.3.4 Novartis Response to COVID-19 and Related Developments
7.4 Merck
7.4.1 Merck Business Overview
7.4.2 Merck Steroids Quarterly Production and Revenue, 2020
7.4.3 Merck Steroids Product Introduction
7.4.4 Merck Response to COVID-19 and Related Developments
7.5 Sanofi
7.5.1 Sanofi Business Overview
7.5.2 Sanofi Steroids Quarterly Production and Revenue, 2020
7.5.3 Sanofi Steroids Product Introduction
7.5.4 Sanofi Response to COVID-19 and Related Developments
7.6 Bayer
7.6.1 Bayer Business Overview
7.6.2 Bayer Steroids Quarterly Production and Revenue, 2020
7.6.3 Bayer Steroids Product Introduction
7.6.4 Bayer Response to COVID-19 and Related Developments
7.7 GSK
7.7.1 GSK Business Overview
7.7.2 GSK Steroids Quarterly Production and Revenue, 2020
7.7.3 GSK Steroids Product Introduction
7.7.4 GSK Response to COVID-19 and Related Developments
7.8 AstraZeneca
7.8.1 AstraZeneca Business Overview
7.8.2 AstraZeneca Steroids Quarterly Production and Revenue, 2020
7.8.3 AstraZeneca Steroids Product Introduction
7.8.4 AstraZeneca Response to COVID-19 and Related Developments
7.9 Cipla
7.9.1 Cipla Business Overview
7.9.2 Cipla Steroids Quarterly Production and Revenue, 2020
7.9.3 Cipla Steroids Product Introduction
7.9.4 Cipla Response to COVID-19 and Related Developments
7.10 Zizhu Pharma
7.10.1 Zizhu Pharma Business Overview
7.10.2 Zizhu Pharma Steroids Quarterly Production and Revenue, 2020
7.10.3 Zizhu Pharma Steroids Product Introduction
7.10.4 Zizhu Pharma Response to COVID-19 and Related Developments
8 SUPPLY CHAIN AND SALES CHANNELS ANALYSIS
8.1 Steroids Supply Chain Analysis
8.1.1 Steroids Supply Chain Analysis
8.1.2 Covid-19 Impact on Steroids Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Steroids Distribution Channels
8.2.2 Covid-19 Impact on Steroids Distribution Channels
8.2.3 Steroids Distributors
8.3 Steroids Customers
9 KEY FINDINGS
10 APPENDIX
10.1 About Us
10.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Steroids Assessment
Table 9. COVID-19 Impact: Steroids Market Trends
Table 10. COVID-19 Impact Global Steroids Market Size
Table 11. Global Steroids Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K MT)
Table 12. Global Steroids Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/MT)
Table 13. Global Steroids Quarterly Market Size, 2020 (US$ Million) & (K MT)
Table 14. Global Steroids Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Steroids Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K MT)
Table 16. Global Steroids Market Growth Drivers
Table 17. Global Steroids Market Restraints
Table 18. Global Steroids Market Opportunities
Table 19. Global Steroids Market Challenges
Table 20. Key Manufacturers Steroids Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Steroids Market Size, 2019 (K MT) & (US$ Million)
Table 22. Steroids Factory Price by Manufacturers 2020 (USD/MT)
Table 23. Location of Key Manufacturers Steroids Manufacturing Plants
Table 24. Key Manufacturers Steroids Market Served
Table 25. Date of Key Manufacturers Enter into Steroids Market
Table 26. Key Manufacturers Steroids Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Steroids Market Size by Type, 2020, (US$ Million)
Table 29. Global Steroids Market Size by Type, 2020 (K MT)
Table 30. Global Steroids Price: by Type, 2020-2021 (USD/MT)
Table 31. Global Steroids Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Steroids Market Size by Application, 2020-2021 (K MT)
Table 33. Global Steroids Price: by Application, 2020-2021 (USD/MT)
Table 34. Global Steroids Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Steroids Market Size by Region, 2019-2021 (K MT)
Table 36. By Country, North America Steroids Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Steroids Market Size, 2019-2021 (K MT)
Table 38. US Steroids Market Size, 2019-2021 (US$ Million) & (K MT)
Table 39. Canada Steroids Market Size, 2019-2021 (US$ Million) & (K MT)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Steroids Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Steroids Market Size, 2019-2021 (K MT)
Table 43. Germany Steroids Market Size, 2019-2021 (US$ Million) & (K MT)
Table 44. France Steroids Market Size, 2019-2021 (US$ Million) & (K MT)
Table 45. UK Steroids Market Size, 2019-2021 (US$ Million) & (K MT)
Table 46. Italy Steroids Market Size, 2019-2021 (US$ Million) & (K MT)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Steroids Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Steroids Market Size, 2019-2021 (K MT)
Table 50. China Steroids Market Size, 2019-2021 (US$ Million) & (K MT)
Table 51. Japan Steroids Market Size, 2019-2021 (US$ Million) & (K MT)
Table 52. South Korea Steroids Market Size, 2019-2021 (US$ Million) & (K MT)
Table 53. India Steroids Market Size, 2019-2021 (US$ Million) & (K MT)
Table 54. ASEAN Steroids Market Size, 2019-2021 (US$ Million) & (K MT)
Table 55. Latin America Steroids Market Size, 2019-2021 (US$ Million) & (K MT)
Table 56. Middle East and Africa Steroids Market Size, 2019-2021 (US$ Million) & (K MT)
Table 57. Sumitomo Business Overview
Table 58. Sumitomo Steroids Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Sumitomo Steroids Product
Table 60. Sumitomo Response to COVID-19 and Related Developments
Table 61. Pfizer Business Overview
Table 62. Pfizer Steroids Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Pfizer Steroids Product
Table 64. Pfizer Response to COVID-19 and Related Developments
Table 65. Novartis Business Overview
Table 66. Novartis Steroids Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Novartis Steroids Product
Table 68. Novartis Response to COVID-19 and Related Developments
Table 69. Merck Business Overview
Table 70. Merck Steroids Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Merck Steroids Product
Table 72. Merck Response to COVID-19 and Related Developments
Table 73. Sanofi Business Overview
Table 74. Sanofi Steroids Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Sanofi Steroids Product
Table 76. Sanofi Response to COVID-19 and Related Developments
Table 77. Bayer Business Overview
Table 78. Bayer Steroids Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Bayer Steroids Product
Table 80. Bayer Response to COVID-19 and Related Developments
Table 81. GSK Business Overview
Table 82. GSK Steroids Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. GSK Steroids Product
Table 84. GSK Response to COVID-19 and Related Developments
Table 85. AstraZeneca Business Overview
Table 86. AstraZeneca Steroids Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. AstraZeneca Steroids Product
Table 88. AstraZeneca Response to COVID-19 and Related Developments
Table 89. Cipla Business Overview
Table 90. Cipla Steroids Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Cipla Steroids Product
Table 92. Cipla Response to COVID-19 and Related Developments
Table 93. Zizhu Pharma Business Overview
Table 94. Zizhu Pharma Steroids Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Zizhu Pharma Steroids Product
Table 96. Zizhu Pharma Response to COVID-19 and Related Developments
Table 97. Steroids Distributors List
Table 98. Steroids Customers List
Table 99. Covid-19 Impact on Steroids Customers
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Steroids Assessment
Table 9. COVID-19 Impact: Steroids Market Trends
Table 10. COVID-19 Impact Global Steroids Market Size
Table 11. Global Steroids Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K MT)
Table 12. Global Steroids Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/MT)
Table 13. Global Steroids Quarterly Market Size, 2020 (US$ Million) & (K MT)
Table 14. Global Steroids Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Steroids Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K MT)
Table 16. Global Steroids Market Growth Drivers
Table 17. Global Steroids Market Restraints
Table 18. Global Steroids Market Opportunities
Table 19. Global Steroids Market Challenges
Table 20. Key Manufacturers Steroids Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Steroids Market Size, 2019 (K MT) & (US$ Million)
Table 22. Steroids Factory Price by Manufacturers 2020 (USD/MT)
Table 23. Location of Key Manufacturers Steroids Manufacturing Plants
Table 24. Key Manufacturers Steroids Market Served
Table 25. Date of Key Manufacturers Enter into Steroids Market
Table 26. Key Manufacturers Steroids Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Steroids Market Size by Type, 2020, (US$ Million)
Table 29. Global Steroids Market Size by Type, 2020 (K MT)
Table 30. Global Steroids Price: by Type, 2020-2021 (USD/MT)
Table 31. Global Steroids Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Steroids Market Size by Application, 2020-2021 (K MT)
Table 33. Global Steroids Price: by Application, 2020-2021 (USD/MT)
Table 34. Global Steroids Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Steroids Market Size by Region, 2019-2021 (K MT)
Table 36. By Country, North America Steroids Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Steroids Market Size, 2019-2021 (K MT)
Table 38. US Steroids Market Size, 2019-2021 (US$ Million) & (K MT)
Table 39. Canada Steroids Market Size, 2019-2021 (US$ Million) & (K MT)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Steroids Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Steroids Market Size, 2019-2021 (K MT)
Table 43. Germany Steroids Market Size, 2019-2021 (US$ Million) & (K MT)
Table 44. France Steroids Market Size, 2019-2021 (US$ Million) & (K MT)
Table 45. UK Steroids Market Size, 2019-2021 (US$ Million) & (K MT)
Table 46. Italy Steroids Market Size, 2019-2021 (US$ Million) & (K MT)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Steroids Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Steroids Market Size, 2019-2021 (K MT)
Table 50. China Steroids Market Size, 2019-2021 (US$ Million) & (K MT)
Table 51. Japan Steroids Market Size, 2019-2021 (US$ Million) & (K MT)
Table 52. South Korea Steroids Market Size, 2019-2021 (US$ Million) & (K MT)
Table 53. India Steroids Market Size, 2019-2021 (US$ Million) & (K MT)
Table 54. ASEAN Steroids Market Size, 2019-2021 (US$ Million) & (K MT)
Table 55. Latin America Steroids Market Size, 2019-2021 (US$ Million) & (K MT)
Table 56. Middle East and Africa Steroids Market Size, 2019-2021 (US$ Million) & (K MT)
Table 57. Sumitomo Business Overview
Table 58. Sumitomo Steroids Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Sumitomo Steroids Product
Table 60. Sumitomo Response to COVID-19 and Related Developments
Table 61. Pfizer Business Overview
Table 62. Pfizer Steroids Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Pfizer Steroids Product
Table 64. Pfizer Response to COVID-19 and Related Developments
Table 65. Novartis Business Overview
Table 66. Novartis Steroids Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Novartis Steroids Product
Table 68. Novartis Response to COVID-19 and Related Developments
Table 69. Merck Business Overview
Table 70. Merck Steroids Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Merck Steroids Product
Table 72. Merck Response to COVID-19 and Related Developments
Table 73. Sanofi Business Overview
Table 74. Sanofi Steroids Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Sanofi Steroids Product
Table 76. Sanofi Response to COVID-19 and Related Developments
Table 77. Bayer Business Overview
Table 78. Bayer Steroids Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Bayer Steroids Product
Table 80. Bayer Response to COVID-19 and Related Developments
Table 81. GSK Business Overview
Table 82. GSK Steroids Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. GSK Steroids Product
Table 84. GSK Response to COVID-19 and Related Developments
Table 85. AstraZeneca Business Overview
Table 86. AstraZeneca Steroids Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. AstraZeneca Steroids Product
Table 88. AstraZeneca Response to COVID-19 and Related Developments
Table 89. Cipla Business Overview
Table 90. Cipla Steroids Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Cipla Steroids Product
Table 92. Cipla Response to COVID-19 and Related Developments
Table 93. Zizhu Pharma Business Overview
Table 94. Zizhu Pharma Steroids Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Zizhu Pharma Steroids Product
Table 96. Zizhu Pharma Response to COVID-19 and Related Developments
Table 97. Steroids Distributors List
Table 98. Steroids Customers List
Table 99. Covid-19 Impact on Steroids Customers
LIST OF FIGURES
Figure 1. Steroids Product Picture
Figure 2. Steroids Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Steroids Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Steroids Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Steroids Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Steroids Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Steroids Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Steroids Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Steroids Market Size Market Share, 2019-2021
Figure 1. Steroids Product Picture
Figure 2. Steroids Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Steroids Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Steroids Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Steroids Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Steroids Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Steroids Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Steroids Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Steroids Market Size Market Share, 2019-2021
